Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation

J Intern Med. 1998 Jul;244(1):79-82. doi: 10.1046/j.1365-2796.1998.00318.x.

Abstract

Objectives: To evaluate the recurrence rate after deep calf-vein thrombosis treated with 6 weeks of oral anticoagulation.

Design and subjects: A 2 year follow-up of 126 consecutive patients admitted to the Department of Internal Medicine with venographically verified deep calf-vein thrombosis.

Results: One hundred and twenty-six patients were treated with warfarin for 6 weeks, 18 of them having had a previous episode of venous thrombosis (DVT). Eleven patients (8.7%) suffered a recurrent thromboembolic episode within 2 years, four of which were within the first 3 months. Eight of those without a history of DVT had a recurrence (7.4%). Three of these were activated protein C (APC)-resistant, one was protein C-deficient and one had malignant melanoma. Eight patients (6.3%) reported minor haemorrhagic complications, but no major bleeding was seen.

Conclusion: Our data support the use of a 6 week regimen of secondary oral prophylaxis after a first episode of deep calf-vein thrombosis in patients without a permanent risk factor. Whether individuals with inherited thrombophilia require prolonged treatment remains to be evaluated.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage*
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Heparin / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Recurrence
  • Thrombophlebitis / drug therapy*
  • Warfarin / administration & dosage*

Substances

  • Anticoagulants
  • Warfarin
  • Heparin